trending Market Intelligence /marketintelligence/en/news-insights/trending/0u1ax_vf-0lrhr48no8ska2 content esgSubNav
In This List

Bio-Rad receives NYSE noncompliance notice for failing to file annual report

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Bio-Rad receives NYSE noncompliance notice for failing to file annual report

Bio-Rad Laboratories Inc. said it received a noncompliance notice from the New York Stock Exchange for failing to file its annual report on time.

The Hercules, Calif.-based life sciences company said the delay was caused by its accounting firm, which is still auditing its results for the fiscal year ended Dec. 31, 2017.

The company has six months from the date the filing was originally due to submit its annual report. Once it files the report, it will regain compliance with the stock exchange's listing requirements.